MedTrace Logo

Transplantation for Patients With Chronic Lymphocytic Leukemia

NCT00186303 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2012-12-17

No results posted yet for this study

Summary

To evaluate the role of high dose therapy and autologous or allogeneic hematopoietic cell transplantation for the treatment of chronic lymphocytic leukemia.

Conditions

  • Leukemia, Lymphocytic, Chronic

Interventions

PROCEDURE

high dose chemotherapy then autologous hematopoietic cell transplant

PROCEDURE

ablative allogeneic hematopoietic cell transplant

Sponsors & Collaborators

Principal Investigators

  • Robert S Negrin · Stanford University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-11-30
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00186303 on ClinicalTrials.gov